Navigation Links
KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
Date:10/11/2007

ward- looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, KV provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of competitive response to the Company's sales, marketing and strategic efforts; (13) risks that the Company may not ultimately prevail in litigation; (14) the proposed restatement of the Company's financial statements for fiscal periods from 1996 through 2006 and for the quarter ended June 30, 2006, as well as completion of the Company's financial statements for the second, third and fourth quarters of fiscal 2007 and for the full fiscal year
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...studies of its kind, researchers say mindful medit...udy, led by doctors at the University of //Wiscons...ion impacts the left side of the brain and has a h...ted 25 people in a work environment with healthy e...
...ake certain types of painkillers, including aspiri...cientists said on Friday. But Paracetomol is not a...regnancy, they added. Researchers in California in...r they became pregnant and asked them about their ...
... achy and don't know why? You could have sinusitis...fflicting Americans.That's the conclusion of new r...in this week's issue of the Archives of Internal M...nist at Georgetown University Medical Center, surv...
...eart attack, the most important thing they can do ...e damage to their heart is to get help as soon as ...to the National Heart, Lung, and Blood Institute, ... when they experience heart attack symptoms becaus...
Other Medicine News:Health News:Recognize Heart Attack Signs 2
(Date:10/6/2008)...- Pharmasset, Inc.,(Nasdaq:... is joining the,Company as Vice President of Inves...ith will be responsible for all investor relations...cial Officer Kurt,Leutzinger., Most recently, Dr....gy,Analyst at JPMorgan Securities, and has been an...
(Date:10/6/2008)...eature children, parents discussing clinical ... Oct. 6 /PRNewswire-USNewswire/ -- From asthma and...en saves lives and improves their,health and well-... of,Health (NIH), "Children and Clinical Studies",...gov ), offers parents and health,care providers an...
(Date:10/6/2008)...t. 6 /- Genaera,Corporation...ond Phase 1,clinical trial of trodusquemine (MSI-1...ent of type 2 diabetes and obesity. MSI-1436 is a ...rget that controls the function,of both the leptin...rease,appetite. In the study, MSI-1436 was found t...
(Date:10/6/2008)...Eliminate 6 Weeks of Radiation Therapy -, Event: W...rnet Wednesday, October 22, 2008, 3 - 4 p.m. by... HAMPTON, Va., Oct. 6 / Questions rac... with breast cancer in May. Would she have the,tum...on or chemotherapy?, , To view the Multimedia Ne...
Breaking Medicine Technology:Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2AvMeds New 2008 Plans Priced 50 25 Less 11514 1AvMeds New 2008 Plans Priced 50 25 Less 11514 2The beauty bias 3A Can people love the one they are compatible with 3F 11512 1The beauty bias 3A Can people love the one they are compatible with 3F 11512 21 year results of bronchial thermoplasty in refractory asthma 11510 11 year results of bronchial thermoplasty in refractory asthma 11510 2Handbook of cancer prevention launched by ESMO 11508 1Handbook of cancer prevention launched by ESMO 11508 2
...ularly engineered,therapy selectively embeds a gen...tumors, inhibits metastasis, and prolongs survival...University of,Texas M. D. Anderson Cancer Center r...s vehicle, or vector, is so targeted and robust in...d for therapy and,perhaps for imaging," notes seni...
...nol,s (SP-233) Ability to Clear Brain,Plaque and E..., In Vivo ,Proof of Concept, Study Proposes Direct...and Memory Recovery , LAS VEGAS, July 10, 2007 (PR...MEX:LIV), a developer of innovative drugs,is plea...-233),efficacy in its ability to dramatically decr...
Other Medicine Technology:Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 2Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 3Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 4Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 5Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 2Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 3
IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULIT
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI
LabDAQ3 opens new windows for the laboratory in flexibility, communication, security, and value. Users can easily move from one function to another. You can review results, validate QC, order tests,
...y for faster, easier, and more accurate automated ...lizes the latest digital FireWire technology, allo... Its ease of use allows technicians to read plates...reduction frees technicians to perform other impor...
Medicine Products: